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A B S T R A C T
Background: The sweetener and hypoglycemic properties of stevioside (STV) are well known, as the main
component of the plant Stevia rebaudiana. Given its extensive use in diabetic patients, it was of interest to
evaluate its effects on the most frequent cardiovascular disease, the coronary insufficiency.
Purpose: To study whether STV could be cardioprotective against ischemia-reperfusion (I/R) in a model of
“stunning” in rat hearts.
Study design: A preclinical study was performed in isolated hearts from rats in the following groups: non-treated
rats whose hearts were perfused with STV 0.3 mg/ml and their controls (C) exposed to either moderate stunning
(20 min I/45 min R) or severe stunning (30 min I/45 min R), and a group of rats orally treated with STV 25 mg/
kg/day in the drink water during 1 week before the experiment of severe stunning in the isolated hearts were
done.
Methods: The mechano-calorimetrical performance of isolated beating hearts was recorded during stabilization
period with control Krebs perfusion inside a calorimeter, with or without 0.3 mg/ml STV before the respective
period of I/R. The left ventricular maximal developed pressure (P) and total heat rate (Ht) were continuously
measured.
Results: Both, orally administered and perfused STV improved the post-ischemic contractile recovery (PICR, as %
of initial control P) and the total muscle economy (P/Ht) after the severe stunning, but only improved P/Ht in
moderate stunning. However, STV increased the diastolic pressure (LVEDP) during I/R in both stunning models.
For studying the mechanism of action, ischemic hearts were reperfused with 10 mM caffeine-36 mM Na+-Krebs
to induce a contracture dependent on sarcorreticular Ca2+ content, whose relaxation mainly depends on mi-
tochondrial Ca2+ uptake. STV at 0.3 mg/ml increased the area-under-curve of the caffeine-dependent con-
tracture (AUC-LVP). Moreover, at room temperature STV increased the mitochondrial Ca2+ uptake measured by
Rhod-2 fluorescence in rat cardiomyocytes, but prevented the [Ca2+]m overload assessed by caffeine-dependent
SR release.
Conclusions: Results suggest that STV is cardioprotective against I/R under oral administration or direct per-
fusion in hearts. The mechanism includes the regulation of the myocardial calcium homeostasis and the en-
ergetic during I/R in several sites, mainly reducing mitochondrial Ca2+ overload and increasing the sarcorre-
ticular Ca2+ store.
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Introduction
Stevioside is a non-caloric sweetener extracted from the leaves of
Stevia rebaudiana (Bertoni) (Asteraceae), a native plant from Paraná in
Brazil, Paraguay and the Northeast of Argentina. This hydrophilic di-
terpenoid glycoside is 300 times sweeter than sugar and concurrently a
good reductor of postprandial blood glucose in type-2 diabetic patients
(Gregersen et al., 2004). It was demonstrated that when orally ad-
ministered to pigs stevioside was strongly converted into its aglycon
steviol by the colonic bacteria (Geuns et al., 2003). It was found that
steviol but not stevioside is the responsible to reduce glucose absorption
(Koyama et al., 2003).
Stevioside (STV) was also described as hypotensor and vasodilator
(Chan et al., 1998; Tirapelli et al., 2010), as diuretic (Melis, 1995) and
bradycardic (Humboldt and Boech, 1997) in preclinical and clinical
studies. It reduced the vascular resistance by inhibition of calcium in-
flux (Melis and Sainati, 1991; Lee et al., 2001; Liu et al., 2003). On line
with this, we described the intestinal antispasmodic effect of STV as-
sociated to a non-competitive blockade of Ca2+-influx to smooth
muscle cells (Matera et al., 2012). Both effects, bradycardia and Ca2+
channels blockade allow us to hypothesize that STV could reduce the
Ca2+ overload induced during ischemia/reperfusion (I/R). Depending
on the duration of ischemia (I), hearts could suffer either a ``stunning”
characterized by reduced contractile recovery and the develop of dia-
stolic contracture during R, or an infarction with necrotic areas and loss
of contractile activity. Two previous studies described that isosteviol, a
derivative compound, induced cardioprotection. In one of them iso-
steviol was perfused from 1 to 10 µmol/l in isolated guinea-pig hearts
exposed to I/R, and the cardioprotection was partially attributed to the
opening of the mitochondrial KATP channels (mKATP) like in myo-
cardial preconditioning (Miura et al., 2001). In the other one, Xu et al.
(2007) demonstrated that isosteviol intravenously injected before oc-
cluding the left coronary artery reduced the size of infarct and the ac-
cumulation of injury marker enzymes such as LDH and creatine-kinase.
These effects observed in a drastic model of I/R were also partially
inhibited by blocking the mKATP (Xu et al., 2007). Since Stevia re-
baudiana and the STV are used as sweetener and hypoglycemic agents
in diabetic patients, it was of interest to assess whether STV could
prevent the consequences of brief episodes of myocardial ischemia.
These episodes are frequently the result of vascular occlusions in dia-
betic or non-diabetic people over 60 years old, and Phytotherapy could
be useful to prevent them. So, we studied the effects of STV on the
mechano-energetical behaviour of isolated rat hearts exposed to two
degrees of stunning. These models provide respectively medium and
low contractile recovery and mitochondrial metabolic changes, which
drive to alterations in muscle economy and Ca2+ handling. These ex
vivo models resemble the clinical situations of a transient coronary
obstruction, after which it is required a prevention to avoid further
ischemic complications to myocardium.
Contractile and calorimetric output of the isolated heart provides
information about the energetic of Ca2+ handling and muscle economy.
Global I/R induces contractile and energetic dysfunction, since meta-
bolism and calcium homeostasis are affected during R (Bolli and
Marban, 1999; Consolini et al., 2007; Valverde et al., 2010; Garcia-
Dorado et al., 2014). Myocardial ischemia reduces the metabolic re-
storation of ATP and the associated heat fraction, but also it reduces the
ATP pool compartmentalized and necessary to extrude Ca2+ from cy-
tosol (Guzun et al., 2015), both of which become in diastolic con-
tracture during I (Consolini et al., 2004, 2007). Still more contracture
appears during first min of R, when the concentrations of H+, Na+ and
Ca2+ increases in cytosol until restoration of mitochondrial metabolism
(Schafer et al., 2001; Valverde et al., 2010). With the reperfusion, the
sarcoplasmic reticulum Ca2+ pump (SERCA), the sarcolemmal Na+/
Ca2+ exchanger (NCX) and the mitochondrial transporters (Ca uni-
porter, mNCX, mKATP and mPTP) play the main roles to restore the
cellular Ca2+ homeostasis (Motegi et al., 2007; Murphy and
Steenbergen, 2008; Bernardi and Di Lisa, 2015; Mattiazzi et al., 2015).
The isolated physiologically perfused whole heart allows to study the
simultaneous and continuous mechano-energetical behaviour before
and during the no-flow ischemia and reperfusion. Then, the aim of this
work was to evaluate the effects of STV on the stunning due to two
degrees of I/R, without infarct. STV was administered either ex vivo and
in vivo to see whether the effects are due to STV or to some metabolite.




The research was conducted in accordance with the internationally
accepted principles for laboratory animal use and care as was re-
commended in the Guide for Care and Use of Animals (NIH Nro pub-
lication # 85-23 revised in 1985 and 1996, National Academy Press,
Washington DC, USA), according to the Resolution 1047 anexo II of
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)
de la República Argentina, 2005.).
Isolated heart preparation and contractile measurements
Adult Sprague-Dawley rats (200 a 250 g weight) of either sex were
heparinized (non-fractioned heparine 2000 IU) and anesthetized with
25% urethane (0.6 ml by 100 g, via i.p.). The animals were sponta-
neously breathing during the general anesthesia. Hearts were rapidly
excised and retrograde perfusion through coronary arteries by the
Langendorffmethod was done, as previously described (Consolini et al.,
2007; Ragone and Consolini, 2009). Hearts were perfused with control
Krebs (C) at 37 °C and at a constant flow rate of 7 ml min−1 g−1, by a
peristaltic pump (Gilson Minipuls, France). This perfusion flow was
calculated by the equation CF = 7.43*HW0.56 (where CF is coronary
flow and HW is the heart weight), valid for different species and re-
commended to prevent heart edema caused by high flow rate of saline
perfusion (Dhein, 2005). This flow was sufficient to develop an optimal
maximal pressure (P) without a significant edema, as described in other
work (Colareda et al., 2016). The experimental conditions (working
temperature, heart rate and I/R periods) were similar to those of pre-
vious studies (Ragone and Consolini, 2009; Consolini et al., 2011;
Bonazzola et al., 2014; Ragone et al., 2015; Colareda et al., 2016) in
which cellular mechanisms had been characterized during stunning of
rat hearts. Atria were removed and the spontaneous beating was
stopped by applying pressure on the focus in the interventricular
septum. A latex balloon was introduced in the left ventricle, connected
by a flexible cannula to a Bentley DEL900 or a Statham P23db pressure
transducer. While continuously perfused, the heart was introduced into
the calorimetrical chamber, which was closed and submerged in a bath
kept at controlled temperature of 37.0 ± 0.01 °C. Rat hearts were
electrically stimulated with 5 V–5 ms at 3 Hz, by means of two elec-
trodes connected to an electrical stimulator (Letica LE12406, Spain or
Grass SD9, USA). The isovolumic left intraventricular pressure (LVP)
was continuously recorded at optimal volume, as well as the total heat
rate. The LVP was recorded during all the experiment either in a
PowerLab 2/26 two channels digital acquisition system (AD Instru-
ments, Australia) or in a Grass polygraph of 8 channels (Grass Instru-
ments, Quincy, MA, USA) with A/D acquisition (TL-1 DMA Axon In-
struments INC., Foster City, CA, USA). The maximal pressure
development (P) of a contraction was calculated from the difference
between the peak in LVP recording and the diastolic level (left ven-
tricular end diastolic pressure (LVEDP)). During I and R there were
calculated the changes in diastolic pressure over the preischemic con-
dition in Krebs-C (ΔLVEDP), in mmHg, as an estimation of diastolic
contracture. Also, during I/R, the pressure development during a con-
traction (contractility) was expressed as a percentage of the steady
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initial value of P in each heart.
Calorimetrical measurements
The calorimeter was previously described (Consolini et al., 2007;
Ponce-Hornos et al., 1982; Ponce-Hornos et al., 1995; Bonazzola et al.,
2014). The internal chamber has two ceramic modules with 127 ther-
mosensitive units (Melchor Thermoelectrics) each one, which detect
changes in temperature between the inside (heart) and the outside
(bath). For details of calibration with a constant electrical power on the
muscle at the end of the experiment, and calorimetrical base lines, see
the previous publications (Consolini et al., 2001; Consolini et al., 2007;
Ragone et al., 2015). The calorimeter was submerged in a water bath at
controlled temperature in connection with other two baths for heating
the perfusates at the same temperature. Heat outputs were recorded
simultaneously to the signal of LVP in the same acquisition system.
Before and after introducing the heart, the calorimetrical signal was
continuously measured in the presence and the absence of perfusion,
which then were used as a base-line in order to be substracted from the
total heat signal in the presence of the heart. Consequently, the total
heat rate (Ht) was calculated from the difference between those signals,
being finally expressed in mW g−1 of wet weight. Also, the ischemic
and post-ischemic measurements were expressed as a percentage of the
steady initial Ht. Finally, the muscle economy was calculated as the P/
Ht ratio.
Experimental protocols
After about 40 min of stabilization with Krebs-C, an ``initial control
value” of P and Ht was recorded, and then hearts were exposed to
different treatments followed by a period of no-flow ischemia (I) and
45 min of reperfusion (R) at 37 °C and 3 Hz of heart rate. The period of I
was characteristic of each model, as follows: 20 min in the moderate
stunning model, and 30 min in the severe stunning model. These
models were previously characterized in hearts perfused only with
control Krebs-C solution (Ragone et al., 2015; Colareda et al., 2016).
Stevioside (STV) was assessed as cardioprotective in both models of
I/R, by perfusing it at a concentration (0.3 mg/ml) which was chosen
from a previous work in which plasmatic concentration was measured
during hypoglycemic effect (Gregersen et al., 2004). Also this con-
centration was effective as an intestinal antispasmodic (Matera et al.,
2012). In the protocols, STV was perfused during 20 min before indu-
cing the no-flow ischemia and remained during this period in contact
with the heart, but then it was removed during reperfusion. As a po-
sitive control, in the model of moderate stunning it was perfused 10 µM
clonazepam (Clzp), a cardioprotective drug which blocks the mNCX
(Cox and Matlib, 1993). In the case of severe stunning it was perfused
30 µM diazoxide (Dzx) a known cardioprotective drug inhibitor of the
mKATP channels (Garlid et al., 2003), as a positive control. Also, it was
done a protocol to evaluate the ``in vivo” administration of STV, by
adding 25 mg STV/kg/day in the drink water during one week, in
agreement to the use as hypoglycemic (Jeppesen et al., 2003).
In order to understand whether STV had an effect on the sarcorre-
ticular Ca2+ content, the ischemic hearts perfused with STV 0.3 mg/ml
and those of a control group (C) were exposed to ischemia and after-
wards reperfused with Krebs containing 10 mM caffeine and 36 mM
Na+ (R-caff-36 Na+). This intervention was classically used to release
Ca2+ from the sarcoplasmic reticulum (SR) proportionally to its content
(Bers, 2001), and prevents the Ca2+ efflux by the sarcolemmal sodium-
calcium exchanger (NCX) due to the reduced Na+ gradient
(Consolini et al., 2007).
Isolation of cardiac myocytes
Ventricular myocytes were isolated from adult rat hearts
(200–280 g weight) as previously described (Bridge et al., 1990;
Ragone et al., 2015). Once the animal was anesthetized the heart was
quickly removed and placed in a Langendorff system. Heart was per-
fused with a modified Krebs-24-HEPES solution virtually free of Ca2+
for 5 min. After that, the solution was changed to Krebs-24-HEPES with
50 µM CaCl2, 0.1 mg/ml collagenase P (Roche) and 0.02 mg/ml pro-
tease XIV (Sigma). After 14 min the solution was changed again to an
enzyme free-50 µM Ca2+ Krebs-24 HEPES solution. All perfusion so-
lutions were bubbled with O2 and maintained at 37 °C. Following this,
the ventricles were removed and minced, and the pieces were shaken in
the low-Ca2+ solution for ten min and then filtered. The Ca2+ con-
centration was raised in steps to 1 mM Ca2+ and myocytes were stored
for up to 6 h in this HEPES-buffered saline solution.
Confocal microscopy with cardiomyocytes
In order to measure changes in the cytosolic free Ca2+ signals,
isolated rat cardiomyocytes were loaded with 12 µM Fluo-4 AM
(Molecular Probes/Invitrogen, Carlsbad, CA, USA) during 15 min at
37 °C. To measure changes in the mitochondrial free Ca2+ signals other
group of cells were loaded with 3 µM Rhod-2 AM (Molecular Probes/
Invitrogen, Carlsbad, CA, USA) during 1 h at 4 °C, followed by a wash-
up at 37 °C during at least 1 h in order to load the fluorophore only in
the mitochondrial compartment (Ragone et al., 2013; Trollinger et al.,
1997). After this, myocytes were placed in a laminin-precoated perfu-
sion chamber and superfused with Krebs-24 HEPES solution containing
2 mM Ca2+ until stabilization. Changes in fluorescence from resting
cells were recorded in a confocal microscope Leica SP5 (Leica Micro-
systems, Mannheim, Germany). Data were analyzed by using the Leica
LAS AF Lite v. 2.2.1 software. When loaded with Fluo-4, cells were
excited at 488 nm, and the changes in fluorescence emission were de-
tected at wavelengths higher than 505 nm in a defined area by cell
(ROI). When loaded with Rhod-2, cells were excited at 540 nm, and the
changes in fluorescence emission from one ROI by cell were monitored
at wavelengths higher than 560 nm. Results were expressed as the self-
ratio emission fluorescence intensity (F/Fo). Changes in F/Fo were
calculated over time by non-linear adjustment of the base-line obtained
during C perfusion at the start and the end of each protocol, by using
Origin 7.0 (OriginLab Corporation, Northampton, MA, USA). Signals
were recorded each 20 s during 25 min while myocytes were perfused
with different protocols, beginning with control Krebs-24 HEPES solu-
tion (C) during 5 min, followed by C+0.3 mg/ml stevioside (C+STV)
during 5 min, then by C with 10 mM caffeine-36 mM Na (C-caff-low Na)
in the presence of STV by 10 min, and finally return to C by 5 min.
Another analogue protocol in the absence of STV was done (control).
For each protocol two series were evaluated, one with Fluo-4 and an-
other with Rhod-2.
Solutions and drugs
Hearts were perfused with Krebs-C (in mM): 1 MgCl2, 125 NaCl, 0.5
NaH2PO4, 7 KCl, 2 CaCl2, 25 NaHCO3, and 6 dextrose, bubbled with
95% O2–5% CO2. Stevioside (STV, 99.8% purity, from Tanki S.A.,
Argentina) was prepared as acqueous solution at 0.3 mg/ml the day of
the experiment. Also, caffeine (ICN, Costa Mesa, CA, USA) was directly
dissolved in Krebs the day of the experiment. Krebs solution with
10 mM caffeine and 36 mM Na+ was kept isosmotic with Krebs-C by
adding 217 mM sucrose.
For cardiomyocytes isolation the solution was (in mM): 126 NaCl,
4.4 KCl, 1.0 NaH2PO4, 5 MgCl2, 24 HEPES, 22 dextrose, 20 taurine, 5
creatine, 0.5 Na-pyruvate, adjusted with NaOH to pH 7.4 and bubbled
with O2 100%. During the experiment cardiomyocytes were superfused
in Krebs-24-HEPES solution with the following composition (in mM):
126 NaCl, 4.4 KCl, 1 MgCl2, 24 HEPES, 2 CaCl2 and 11 dextrose, ad-
justed with NaOH to pH 7.4 and bubbled with O2 100%. For Fluo-4
experiments 0.5 mM probenecid was added.
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Statistical analysis
Results were expressed as mean± SEM. Multiple comparisons by
two-way ANOVA for repeated measures (factors were treatment and
time) were done for the respective groups of experiments. Also, paired
t-tests and one-way ANOVA were used when appropriate. Bonferroni
paired post-tests were done among the treatments when a significant
difference was found by ANOVA, and their results are shown in each
figure. Always a significance level of p <0.05 was considered. All
statistical analyses were performed by using the Graph Pad Prism v.4
software.
Results
Effects of stevioside in rat hearts exposed to moderate stunning
Hearts perfused with control Krebs had an initial maximal pressure
development (P) of 77.8 ± 10.0 mmHg and a diastolic pressure
(LVEDP) of 10.1 ± 0.9 Hg, and released an steady heat rate (Ht) of
17.9 ± 1.4 mW g−1 (n =8). The period of 20 min I–45 min R induced
a moderate stunning in non-treated rat hearts (C group) with a post-
ischemic contractile recovery (PICR) of about 60% of the initial P
(Fig. 1A). The presence of 0.3 mg/ml stevioside (STV) did not sig-
nificantly modify P, LVEDP or Ht (respectively 69.9 ± 8.7 mmHg,
11.3 ± 2.5 mmHg and 16.7 ± 1.4 mW g−1). Perfusion of STV before I
also did not change the PICR obtained during reperfusion with Krebs-C
(R) although it slowed contractile recovery. Contrarily, the positive
control with 10 µM clonazepam (Clzp) improved PICR to about 100%.
Simultaneously, during R control hearts recovered the total heat rate
(Ht) when metabolism and active transport mechanisms were re-
activated with the consequent energetic consumption. Fig. 1B shows
that both, STV and Clzp reduced Ht of rat hearts during R with respect
to the control group. When comparing contractility with the energetic
output, the P/Ht ratio shows the total muscle economy. Fig. 1C shows
that control hearts slightly reduced P/Ht during R regarding the pre-
ischemic condition, but STV and Clzp significantly increased it, showing
a cardioprotective effect. Nevertheless, Table 1 shows that, unlike
hearts non-treated (C) or perfused with Clzp which reduced the dia-
stolic pressure (ΔLVEDP) during I and slightly increased it during R,
STV increased the diastolic pressure during all the period of I/R.
Effects of stevioside in rat hearts exposed to severe stunning
The period of 30 min I–45 min R induced a severe stunning in non-
treated rat hearts (C group) with a PICR of about 15% of the initial P
(Fig. 2A). The presence of 0.3 mg/ml stevioside (STV) before and
during I significantly increased the PICR to about 35% of initial P at the
end of R, while the positive control with 30 µM diazoxide (Dzx) im-
proved PICR to about 85% of initial P. Simultaneously, STV increased
the total muscle economy (P/Ht) from about 14% (C group) to near
60% (STV group) and Dzx to 125% of initial, indicating a better con-
tractile recovery with low energetic consumption (Fig. 2B). This was an
important cardioprotective effect of both, STV and Dzx, in spite of the
increased diastolic contracture (ΔLVEDP) induced by perfusing 0.3 mg/
ml STV during severe I/R while Dzx reduced it (Table 1).
When rats were orally treated with STV (25 mg/kg/day in the water
drink during one week) the isolated hearts exposed to severe ischemia
(30 min I and 45 in R) recovered P to about 36% of initial, more than
the respective group of control hearts and the same than when STV was
perfused in hearts (Fig. 2C). Moreover, STV improved the total muscle
economy to about 42% of initial (Fig. 2D) but it maintained the dia-
stolic contracture of C-hearts, preventing the increase seen in hearts
perfused with STV before I/R (Table 1).
(caption on next page)
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Effects of stevioside on the sarcorreticular Ca2+ content
To evaluate whether the cardioprotective effects of STV were due to
an increase in the sarcorreticular (SR) Ca2+ content, some experiments
were performed in which after the treatment with STV or Krebs-C and
ischemia, the hearts were reperfused with Krebs containing 10 mM
caffeine, in order to release the SR Ca2+, and 36 mM Na+ to minimize
the efflux through the NCX (Krebs-caff-low [Na+]). Such protocol of
reperfusion was applied to both models: moderate and severe stunning.
In all cases, R with Krebs-caff-low [Na+] induces a disappearance of
beating and a contracture evidenced by the maintained increase in
pressure over the ischemic level (ΔLVP), a rise in Ht associated to the
myofilaments interaction, Ca2+ cycling through the SR and mitochon-
dria along with the caffeine activation of RyR2 channels, and the Ca2+
removal mechanisms for relaxation (Consolini et al., 2007).
Fig. 3A shows that in the moderate stunning STV reduced the re-
laxation rate of the contracture induced by Krebs-caff-low [Na+] (ΔLVP
fell more slowly over time) and increased the area under the curve of
contracture (AUC-ΔLVP) (Table 2). The simultaneous heat rate (Ht) was
not changed by STV (Fig. 3B) as neither the AUC-Ht (Table 2). In the
severe stunning, the ΔLVP was increased by STV during I and during the
caffeine-low [Na+] reperfusion, without changing the relaxation rate
(Fig. 3C). The AUC-ΔLVP had a non significant tendency to increase in
hearts treated with STV (Table 2). The Ht and the AUC-Ht associated to
the contracture were not modified by STV in this model (Fig. 3D,
Table 2).
The effect of STV on the SR Ca2+ content was also evaluated in the
well oxygenated isolated cardiomyocytes without electrical stimula-
tion. The change of perfusion from control HEPES-Krebs (C) to HEPES-
Krebs with 10 mM caffeine-36 mM Na+ induced a transient increase in
the relative fluorescence (ΔF/Fo) signal of Fluo-4 followed by an abrupt
fall to basal level (Fig. 4A), at the time in which the ΔF/Fo of Rhod-2
was slowly increased (Fig. 4B). Control condition shows that caffeine
induced the SR Ca2+ release to cytosol (Fluo-4 signal), but mitochon-
dria slowly uptake this Ca2+ (Rhod-2 signal). Addition of STV did not
change the raise and fall of cytosolic Ca2+ induced by Krebs-caff-low
[Na+] (Fluo-4 ΔF/Fo) (Fig. 4A). However, STV increased the Rhod-2
ΔF/Fo before applying the Krebs-caff-low [Na+] perfusion and also
sped up the mitochondrial uptake during it, while reduced the final
increase in free [Ca2+]m during the Krebs-caff-low [Na+] perfusion
and the turning back to C (Fig. 4B). Results suggest that in non-ischemic
cardiomyocytes STV increased the mitochondrial Ca2+ cycling but re-
duced the mitochondrial Ca2+ overload.
Discussion
This work describes direct effects of STV on two models of stunning,
moderate and severe, in isolated rat hearts. Myocardial contractility
and the energetic behaviour were measured during ischemia and re-
perfusion (I/R). Results show that this frequently consumed sweetener
improved the myocardial contractile and energetic recovery after a
transient and a more severe ischemia, becoming in a cardioprotective
agent. Some aspects of its mechanism were characterized.
It is known that ischemia and reperfusion becomes in several types
of myocardial contractile dysfunction, in a range from the stunning to
the infarct, and electrical alterations which generate arrhythmias. The
experimental models to study these pathologies are based in the iso-
lated perfused heart, since it gives the possibility of simulating the
cessation or reduction in perfusion flow (Consolini et al., 2001, 2007).
In the last years, the mouse isolated perfused heart was used to si-
multaneously study the changes in contractility, [Ca2+] in cytosol and
sarcoplasmic reticulum (SR), and the action potential during I/R in a
stunning model (Valverde et al., 2010). Ischemia induces reduction in
the duration of action potential (Cole et al., 1991) causing less Ca2+
influx and activation of ryanodine receptors (RyR2) (Fauconnier et al.,
2013). Valverde et al. (2010) explained that during I the SR maintains
the Ca2+ store and during the first min of R the SR quickly loses it to
cytosol, becoming in an increased diastolic contracture. The subsequent
Ca2+ induced-Ca2+ release events of SR are reduced during reperfusion
as well as the Ca2+ transients, thus explaining the reduced contraction
(stunning). Also, I/R induces an energetic debt, because of reduction in
aerobic metabolism and ATP synthesis. We described that ischemic rat
hearts reduced the total muscle economy (P/Ht) during R, due to a
lower contraction with diastolic contracture and high energetic cost
evidenced by the high heat release (Consolini et al., 2007). We also
demonstrated the important role of mitochondria to regulate the SR
content and the postischemic contractile recovery (PICR) with Ca2+
extrusion through the mitochondrial Na+/Ca2+-exchanger (mNCX)
(Ragone and Consolini, 2009; Consolini et al., 2011; Ragone et al.,
2013; Ragone et al., 2015). With this knowledge, we analyzed the
present results in isolated rat hearts perfused with STV at a con-
centration in which it demonstrated antispasmodic effect in isolated
intestine associated to Ca2+ influx inhibition (Matera et al., 2012).
Also, the cardioprotective effect was found in rats treated with STV in
drinking water, a condition that imitates the human consumption of
this sweetener
The results obtained in the moderate stunning model (Fig. 1) show
that STV improved the recovery of total muscle economy (P/Ht), but
maintained the PICR and increased the diastolic contracture during I/R
(Table 1). Contrarily, the inhibitor of mNCX clonazepam increased
PICR and P/Ht and reduced LVEDP, in agreement with the increase in
[Ca2+]m and activation of metabolism and ATP synthesis (Cox and
Matlib, 1993). These results suggest that STV did not change the SR
Ca2+ release but reduced the mitochondrial metabolism, and increased
the diastolic Ca2+ leak to cytosol. To understand the Ca2+ homeostasis
during R, ischemic rat hearts were reperfused with 10 mM caffeine-
36 mM Na-Krebs, since this caffeine concentration induces opening of
Fig. 1. Effects of 0.3 mg/ml stevioside (STV) on the maximal pressure development (P)
(as % of the initial value, A), total heat rate (Ht) (as % of initial value, B) and muscle
economy (P/Ht as % of initial value, C) of rat hearts exposed to 20 min ischemia (I) and
45 min reperfusion (R) in a moderate stunning model, in comparison with non-treated
hearts (Control). Positive control of hearts perfused with 10 µM clonazepam (Clzp) was
also shown. STV and Clzp were perfused before I and remained during it. Results are
shown as media± SEM (n are indicated in panel A) (two-way ANOVA's by treatment:
F =16.86, F = 23.35 and F = 24.73, all p<0.0001 respectively for A, B and C; by time:
F = 86.23, 52.29 and 52.78, respectively for A, B and C, all p<0.0001. Post-tests
*p<0.05 vs. Control).
Table 1
Changes in the left ventricular end diastolic pressure (ΔLVEDP in mmHg) over the pre-
ischemic value induced by ischemia and reperfusion in rat hearts exposed to the models of
moderate or severe stunning (see the text). Before ischemia, the hearts were perfused with
control Krebs (C) or stevioside 0.3 mg/ml (C+STV) and another group was treated with
STV 25 mg/kg/day orally during one week before (*p<0.05 vs C by t-tests or by
Bonferroni post-test after ANOVA, respectively for moderate and severe stunning, number
of experiments in parenthesis).
Treatment 5 min I End of I 5 min R 45 min R
Moderate stunning at 37 °C:
C (7) –3.5 ± 0.9 –0.5 ± 0.8 7.7 ± 1.9 1.7 ± 0.6
C + STV 0.3 mg/ml
(8)
12.2 ± 3.7* 30.6 ± 5.8* 60.2 ± 3.7* 53.5 ± 6.3*
C + Clzp 10 µM (6) –10.0 ± 4.9 –7.1 ± 4.9 6.0 ± 2.9 4.3 ± 2.7
ANOVA F =10.96 F =20.19 F = 108.4 F = 46.02
p =0.0008 p <0.0001 p <0.0001 p <0.0001
Severe stunning at 37 °C:
C (6) –6.3 ± 3 7.5 ± 3.8 17.9 ± 2.6 16.2 ± 3.8
C + STV 0.3 mg/ml
(5)
13.6 ± 7.8* 25.0 ± 8.7 81.8 ± 8.6* 66.4 ± 6.5*
C + STV oral
25 mg/kg (5)
–6.7 ± 4.9 6.2 ± 3.1 21.2 ± 8.3 10.9 ± 0.8
C + Dzx 30 µM (5) –1.4 ± 1.4 –0.8 ± 2.3 9.4 ± 3.5 4.9 ± 1.5
ANOVA F =3.94 F =4.60 F = 28.69 F = 51.35
p =0.0265 p =0.0156 p <0.0001 p <0.0001
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RyR2 with the consequent massive release of Ca2+ from the SR pro-
portionally to its content (Bers, 2001). The resultant contracture was
accompanied by an increase in Ht, which can be attributed to a Ca2+
cycling between SERCA and RyR2. This is because Ca2+ can not be
extruded by the sarcolemmal NCX at low [Na+]o, but it can be removed
by the mitochondrial uniporter, with the consequent dissipation of their
electrochemical gradient, metabolism activation and heat release
(Consolini et al., 2007). In comparison with the non-treated hearts
(control) STV increased the AUC-ΔLVP associated to a slight reduction
in the relaxation rate of the caffeine-induced contracture (Fig. 3A). This
result suggests that Ca2+ was extruded more slowly from cytosol by the
mitochondrial uptake, which is the main Ca2+ removal mechanism
when SERCA and NCX are minimized. The fact that STV did not change
Ht during the contracture suggests that the reduction in mitochondrial
metabolism when Ca2+ is collected was compensated by a same in-
crease in energetical consumption to remove the remaining cytosolic
Ca2+. In the cytosolic side, the heat released by SERCA futile cycling is
equivalent to the enthalpy of ATP for moving 2 Ca2+ (40 mJ/µmol
Ca2+) while NCX is minimized but sarcolemmal Ca2+ ATPases could
effectively remove Ca2+ by consuming 80 mJ/µmol Ca2+ (1 ATP for 1
Ca2+,). On the mitochondrial side, the energetic equivalent is 477 mJ/
µmol O2 or 80 mJ/µmol Ca2+ (since the electron transport chain moves
12 H+/O2, and 1 Ca2+/2H+) (Curtin and Woledge, 1978). Also, the
actomyosin crosstalk during the contracture consumes ATP and releases
heat (Mulieri and Alpert, 1982).
In the severe stunning model STV was more cardioprotective than in
the moderate stunning one, with a definite increment in the PICR and
muscle economy (compare Figs. 1 and 2). This effect is qualitatively
similar to that obtained with the known cardioprotective diazoxide,
which activates the KATP channels and consequently reduces the mi-
tochondrial Ca2+ overload (Garlid et al., 2003). Nevertheless, perfusion
of STV induced increase in LVEDP during I/R in both models but it was
more important in the severe stunning. Considering that I/R increases
the Ca2+ leak from SR (Valverde et al., 2010; Mattiazzi et al., 2015),
the effect of STV on PICR and ΔLVEDP suggests that it may be in-
creasing both, the SR Ca2+ content and the leak during I/R. In fact, the
reperfusion with 10 mM caffeine-36 mM Na+-Krebs increased the in-
itial peak of contracture after treatment with STV, which suggests an
increase in the SR Ca2+ store released by caffeine (Bers, 2001). In
control conditions, the AUC-ΔLVP of hearts exposed to severe I/R was
Fig. 2. Effects of stevioside (STV) on the severe stunning developed by 30 min ischemia (I) and 45 min reperfusion (R) at 37 °C in comparison with non-treated hearts (C, control). A and B
show the effect of perfusing 0.3 mg/ml STV and the positive control 30 µM diazoxide (Dzx), while C and D show the effects of administering 25 mg/kg/day orally during one week before
I/R. The upper graphs show maximal pressure development (P) (as % of the initial value), the lower graphs show muscle economy (P/Ht as % of initial). Results are shown as
media± SEM (n are indicated in panels A and C) (two-way ANOVA's for A and B: by treatment F = 154.2, and F = 80.37, both p <0.0001, and by time: F = 296.6 and 67.61, both
p <0.0001, respectively; and for C and D: by treatment F = 144.4, p <0.0001, and F =8.959, p =0.003, and by time: F = 196.8 and 26.93 both p <0.0001, respectively; Post-tests
*p<0.05 vs. Control).
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similar to that obtained with moderate stunning, suggesting that the SR
did not lose Ca2+ after 10 min more of ischemia (Table 2). STV in-
creased the LVP during the whole period of I and R-caff low [Na+]
respect to the control group, and had a tendency to increase the AUC-
ΔLVP. Simultaneously, Ht and AUC-Ht were similar for both groups of C
and STV, again suggesting that the changes in Ca2+ movements were
energetically equivalents.
When non-ischemic cardiomyocytes were perfused with 10 mM
caffeine in a 36 mM Na+-Krebs, cytosolic [Ca2+] (F/Fo Fluo-4) was
increased and then reduced at the time in which the mitochondrial
[Ca2+] (F/Fo Rhod-2) was raised (Fig. 4). These responses show that
after the caffeine-dependent SR release the cytosolic Ca2+ was removed
towards mitochondria. Perfusion of STV during the caffeine treatment
did not change the pattern of cytosolic [Ca2+]. Nevertheless, mi-
tochondrial [Ca2+] was early increased by STV but afterwards it was
reduced regarding control cells. This pattern suggests that in non-is-
chemic myocytes STV increased both, mitochondrial Ca2+ uptake by
UCam and Ca2+ extrusion by mNCX. We have previously described that
this pathway provides the functional interaction between mitochondria
and the SR store to regulate PICR (Ragone and Consolini, 2009). The
mitochondrial Ca2+ uptake activates metabolism, and consequently the
oxidative phosphorylation, explaining that reperfused hearts previously
treated with STV have a higher muscle economy (P/Ht) in all models.
Nevertheless, the contracture obtained by reperfusing ischemic hearts
with 10 mM caffeine-low [Na+] Krebs was more slowly relaxed after
STV treatment, suggesting that ischemia changed the STV effect to at-
tenuate the mitochondrial Ca2+ uptake. Since mitochondria and SR
determine a balance of Ca2+ movements, the reduced mitochondrial
uptake becomes in increased SR Ca2+ store, thus raising the Ca2+-in-
duced Ca2+ release and the force of contraction. The cardioprotection
of STV was greater in the model of severe stunning in rats orally treated
Fig. 3. Effects of 0.3 mg/ml stevioside (STV) on the sarcorreticular content estimated by postischemic reperfusion with 10 mM caffeine-36 mM Na-Krebs, in rat hearts exposed to 20 min
ischemia (A-B) or to 30 min ischemia (C-D) at 37 °C. The changes on left ventricular pressure (ΔLVP) over the control preischemic condition (in mmHg) and (n) are shown in A and C, and
the absolute values of heat rate (Ht in mW.g−1) are shown in B and D (Two-way ANOVA's: for A and B: by treatment F = 1.868, p=0.17, and F = 0.02, p=0.88 NS; and by time:
F =144.9 and 45.65, both p<0.0001, respectively; for C and D in severe stunning: by treatment F = 57.55, p<0.0001, and F = 6.02, p=0.014; and by time: F = 104.1 and
F =34.67, both p<0.0001, respectively). Tests a posteriori: *p<0.05 vs. Control.
Table 2
Area under the curves of intraventricular pressure (ΔLVP) and heat rate (ΔHt) over the
end of ischemia value, during the reperfusion with Krebs-C-10 mM caffeine- 36 mM Na+
on rat hearts with the different treatments described in the text. (*p< 0.05 versus
Control).
Treatment AUC-ΔLVP (mmHg min) AUC-ΔHt (mW min/g)
Moderate stunning at 37 °C:
Control (7) 2114.9 ± 349.6 504.5 ± 86.1
C+STV 0.3 mg/ml (6) 3063.6 ± 241.8* 493.4 ± 75.8
Severe stunning at 37 °C:
Control (11) 2428.9 ± 193.7 297.6 ± 46.7
C+STV 0.3 mg/ml (6) 2838.0 ± 365.7 279.5 ± 20.9
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with 25 mg/kg/day STV, since it increased PICR without important
diastolic contracture (Fig. 2 and Table 1). These effects suggest that oral
STV increased the SR Ca2+ store with a reduced leak. The differences
between both models of STV administration previous to severe
ischemia, suggest that part of the effect of STV may be due to a meta-
bolite, such as the described isosteviol, which would reduce the SR
Ca2+ leak induced by STV. It was reported a human doses of 1 g ste-
vioside/day in diabetic patients, equivalent to 17 mg/kg for a patient of
60 kg, which resulted in a plasmatic concentration of about 0.33 mg
STV/ml (Gregersen et al., 2004). Thus, the oral doses of 25 mg/kg/day
is equivalent to that used in humans, as well as the concentration used
for perfusing the isolated hearts was equivalent to the plasmatic con-
centration. In conclusion, this work shows that STV is a cardioprotec-
tive agent, which increases the sarcorreticular Ca2+ release, and could
be preventive of stunning for patients that have any risk factor of cor-
onary dysfunction which causes a transient period of ischemia and re-
perfusion.
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